Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Adicionar filtros








Intervalo de ano
1.
Artigo em Chinês | WPRIM | ID: wpr-1018220

RESUMO

Deficiency, stasis, water and toxin are of great significance in the pathogenesis and pathologic evolution of chronic heart failure (CHF). Based on "deficiency, blood stasis, water and toxin", the pathogenesis and treatment of CHF were discussed in this article. It was found that in the pathogenesis, deficiency--deficiency of heart qi and deficiency of heart yang were the origin of the disease, and blood stasis, water and toxin were the markers of the disease. Among them, blood stasis was the central pathological link, and also an important mechanism that could aggravate the disease and cause a vicious cycle; water-phlegm and water dampness were the basic pathological products; toxin-heat toxin, water toxin, and stasis toxin were the final results of disease progress and product accumulation. In terms of treatment, CHF can be divided into four stages: early, middle, late and end. In the early stage, tonifying qi and regulating heart can be used for the treatment of root cause, and promoting blood circulation and water can be used for the treatment of symptoms; tonifying qi and yin and reinforcing the healthy qi, reducing blood stasis, purging turbid, and eliminating pathogenic factors can be used in the middle stage; reducing blood stasis and removing toxic materials should be used in the late stage, supplemented with warming yang and increasing urine excretion; astringing yang,generating body fluids, tonifying qi and yang should be used in the end stage. At the same time of treating by stages, attention should be paid to adhering to a holistic concept and dialectical treatment; pay attention to timing and flexible medication; adopting a combination of Chinese and Western approaches and integrating them.

2.
Artigo em Chinês | WPRIM | ID: wpr-940127

RESUMO

Chronic heart failure is a serious heart disease with dyspnea and limited activity tolerance as the main clinical manifestations. Activation of the inflammatory system can significantly stimulate cardiac fibrosis and remodeling and promote the progression of heart failure, playing a key role in the development of the disease. Studies have confirmed that inflammation is involved in the development of different types of heart failure. "Toxic pathogen theory" is an important basic theory of traditional Chinese medicine (TCM) to explain the occurrence of diseases. We concluded the similarities between TCM toxic pathogens and inflammation in concept, disease location, etiology, syndrome differentiation, and clinical characteristics. Chronic heart failure is manifested by the toxic pathogens of turbid phlegm, stagnated blood, and accumulated fluid. Heart vessel obstruction is the main pathological factor, and the inflammatory factors produced by necrotic cardiomyocytes are the microscopic manifestations of the obstruction. Therefore, based on the "toxic pathogen theory", this study aimed to clarify the role of inflammation in the development of chronic heart failure from both macroscopic and microscopic perspectives. Moreover, this paper proposed that the stagnated blood has not been transformed into toxin in the early stage of the disease and thus the products of clearing heat and detoxification should not be used. At the development stage of the disease when the transformation tends to begin, treatment should be based on syndrome differentiation, and detoxifying Chinese medicine should be used in order to achieve the goal of "removing toxin without harming the healthy Qi". At the late stage of heart failure, toxins have been accumulated and detoxifying medicines and therapies should be applied to eliminate the toxic pathogens. This study is expected to lay a foundation for the modern research on the role of inflammation in the development of chronic heart failure with TCM theory and guide the diagnosis and treatment of this disease.

3.
Artigo em Chinês | WPRIM | ID: wpr-940224

RESUMO

Chronic heart failure is a serious heart disease with dyspnea and limited activity tolerance as the main clinical manifestations. Activation of the inflammatory system can significantly stimulate cardiac fibrosis and remodeling and promote the progression of heart failure, playing a key role in the development of the disease. Studies have confirmed that inflammation is involved in the development of different types of heart failure. "Toxic pathogen theory" is an important basic theory of traditional Chinese medicine (TCM) to explain the occurrence of diseases. We concluded the similarities between TCM toxic pathogens and inflammation in concept, disease location, etiology, syndrome differentiation, and clinical characteristics. Chronic heart failure is manifested by the toxic pathogens of turbid phlegm, stagnated blood, and accumulated fluid. Heart vessel obstruction is the main pathological factor, and the inflammatory factors produced by necrotic cardiomyocytes are the microscopic manifestations of the obstruction. Therefore, based on the "toxic pathogen theory", this study aimed to clarify the role of inflammation in the development of chronic heart failure from both macroscopic and microscopic perspectives. Moreover, this paper proposed that the stagnated blood has not been transformed into toxin in the early stage of the disease and thus the products of clearing heat and detoxification should not be used. At the development stage of the disease when the transformation tends to begin, treatment should be based on syndrome differentiation, and detoxifying Chinese medicine should be used in order to achieve the goal of "removing toxin without harming the healthy Qi". At the late stage of heart failure, toxins have been accumulated and detoxifying medicines and therapies should be applied to eliminate the toxic pathogens. This study is expected to lay a foundation for the modern research on the role of inflammation in the development of chronic heart failure with TCM theory and guide the diagnosis and treatment of this disease.

4.
Artigo em Chinês | WPRIM | ID: wpr-940770

RESUMO

ObjectiveTo observe the difference in the efficacy of three kinds of traditional Chinese medicine (TCM) injections on rat model of heart failure induced by transverse aortic constriction (TAC), explore the TCM syndrome of the model based on the theory of correspondence of prescription and syndrome, and reveal the biological basis of prescription-syndrome from the perspective of metabolism. MethodRats were treated with TAC for modeling and were divided into Shenmai injection group (6.0 mL·kg-1), model group, Danhong injection group (6.0 mL·kg-1), Shenfu injection group (6.0 mL·kg-1) and trimetazidine group (10 mg·kg-1), and sham operation group was set up as control. After drug intervention for 15 days, echocardiography, serum N-terminal pro-brain natriuretic peptide (NT-proBNP) and myocardial histopathological staining were performed for each group, so as to compare the efficacy to select the effective injection. Colorimetry was used to detect the serum glucolipid metabolism after the intervention of the effective injection, and ultra high performance liquid chromatography-mass spectrometry was used to observe the metabolites and related metabolic pathways in myocardial tissue. ResultCompared with the sham operation group, the left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (FS) in the model group decreased (P<0.01), while the left ventricular end-diastolic diameter (LVIDd), left ventricular internal diameter at end-systole (LVIDs) and NT-proBNP level increased (P<0.01). Compared with model group, LVEF and FS increased (P<0.01), LVIDd, LVIDs and NT-proBNP level decreased (P<0.05, P<0.01) in Danhong injection group, NT-proBNP level in Shenfu injection group decreased (P<0.05), LVIDd and NT-proBNP level increased (P<0.05, P<0.01) in Shenmai injection group, in trimetazidine group, LVEF and FS increased (P<0.01), while LVIDs and NT-proBNP level decreased (P<0.05, P<0.01). Serum glucose, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol levels in Danhong injection group and trimetazidine group were adjusted by callbacks (P<0.01, P<0.05). There were the callback of 9 myocardial metabolites in Danhong injection group, including glycine, serine and threonine metabolism, glyoxylate and dicarboxylate metabolism, glycerol phospholipid metabolism. There were the callback of 10 myocardial metabolites in trimetazidine group, including glycerol phospholipid metabolism. ConclusionThe efficacy of Danhong injection on heart failure model induced by TAC is significant and superior to Shenfu injection and Shenmai injection, suggesting that the model is closely related to heart-blood stasis. The biological mechanism of Danhong injection interfering with the model involves regulating the metabolic disorder of lipid, glucose, amino acid and butyric acid.

5.
Artigo em Chinês | WPRIM | ID: wpr-819042

RESUMO

Severe combined immunodeficiency disease (SCID) is a group of rare congenital diseases characterized by severe deficiencies in T lymphocyte counts and/or function. The recurrent, persistent and severe infections are its clinical manifestations. Neonatal screening and immune system reconstruction would improve the prognosis of SCID children. Newborn screening programs based on T-cell receptor excision circles (TRECs) quantitative detection have been carried out in clinical practice, however, the methods still have some limitations. Other new methods such as mass spectrometry and T lymphocyte-specific biomarker assays are still under investigation. Hematopoietic stem cell transplantation and gene therapy are the two main methods for reconstructing immune function in SCID children. Through improving the success rate of transplantation and the long-term safety and stability of viral vectors, some achievements have been made by many centers already. However, large-scale prospective studies are needed for evaluation of the long-term efficacy. In this article, the recent progress in newborn screening and immune reconstitution of SCID is reviewed.


Assuntos
Humanos , Recém-Nascido , Reconstituição Imune , Triagem Neonatal , Estudos Prospectivos , Imunodeficiência Combinada Severa , Terapêutica , Linfócitos T
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA